Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - OTHER LIABILITIES
Other Liabilities NVAX - Novavax, Inc.
91 M
LAST VALUE
46.97%
2 YEAR CAGR
59.96%
5 YEAR CAGR
50.09%
10 YEAR CAGR